IONIS PHARMACEUTICALS INC — Director's Dealing 2020

Sep 2, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IONIS PHARMACEUTICALS INC (IONS)
CIK: 0000874015
Period of Report: 2020-08-31

Reporting Person: Monia Brett P (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-31	Common Stock	J	236	$44.455	Acquired	29193	Direct
2020-09-01	Common Stock	S	314	$53.7	Disposed	28879	Direct

Footnotes

F1: Reporting 236 shares acquired under the Ionis Pharmaceuticals, Inc. Amended and Restated 2000 Employee Stock Purchase Plan on August 31, 2020. These 236 shares may not be sold until February 28, 2021

F2: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on 10/7/2019.